AR

Abhijay Rao Vemulapalli

Active Director Director DIN 09829773
DIN 09829773 First appointment Dec 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhijay Rao Vemulapalli

Data last updated:

Abhijay Rao Vemulapalli is a Director at Flavum Healthtech Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09829773
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 20 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Flavum Healthtech Private Limited U85300JH2022PTC019744
Director20 Dec 20222022Active

Board colleagues of Abhijay Rao Vemulapalli

NameDINCompanyDesignation
Pooja Tripathi09000239Flavum Healthtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Flavum Healthtech Private Limited
Premium access

Shareholding and investment profile for Abhijay Rao Vemulapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijay Rao Vemulapalli

Abhijay Rao Vemulapalli currently holds 1 directorship: Flavum Healthtech Private Limited (Director, since 20 Dec 2022).

Abhijay Rao Vemulapalli was first appointed on 20 Dec 2022 as Director at Flavum Healthtech Private Limited.

The current boards of Abhijay Rao Vemulapalli's companies include Pooja Tripathi (Flavum Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available